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Adsorption of complement factor D by potyacrylonitrile dialysis mem-
branes. Factor D, an essential enzyme of the alternative pathway (AP)
of complement, accumulates in end-stage renal failure (ESRF). Poly-
acrylonitrile (PAN) membrane activates complement poorly and has
been shown to adsorb C3a, the main anaphylatoxin released during
complement activation. In the present work we investigated whether
factor D might be adsorbed on PAN. In vitro there was a loss of
hemolytic factor D when normal human serum (NHS) was incubated
with PAN dialysis fibers, whereas no loss was observed with cuprophan
(Cu) fibers. There was a dose and time dependent binding of purified
radiolabeled factor D to PAN but not to Cu. The hemolytic function of
factor D released from PAN by 2 M NaC1 was normal. By contrast,
factor D was inactive while adsorbed to PAN fibers. When 50 ml of
NHS or 100 ml of whole blood were passed through a new hollow fiber
PAN dialyzer 95% of factor D was adsorbed. The eluate from a PAN
filter which had been used for dialysis in a patient with ESRF contained
38.4 mg of hemolytic factor D, representing 34% of the proteins eluted.
By immunoblotting, antigenic factor D from the PAN eluate was
identical to purified human factor D. In six patients there was a 81.4%
decrease in hemolytic factor D in blood after dialysis with PAN,
contrasting with a 9.6% decrease in those dialyzed with cellulose
acetate. No factor D was found in the dialysis fluid of PAN dialyzers,
indicating that PAN removed factor D mainly by adsorption. In
conclusion, PAN has a significant capacity to adsorb factor D, a
reaction that might contribute to the diminished capacity of PAN
membrane to activate the AP of complement. Whether the efficient
removal of large amounts of factor D might be beneficial in uremic
patients remains to be defined.
The contact of blood with biomaterials triggers the coagula-
tion and complement cascades [1—8]. Dialysis membranes have
been selected on the basis of minimal activation of both to avoid
thrombosis and adverse reactions related to the formation of
complement fragments. Complement activation occurs mainly
through the alternative pathway (AP) and is due to the direct
interaction between complement proteins and the chemical
residues on the dialysis membrane [9—111. The activation of
complement depends on a fine balance between various inter-
actions which either favor or inhibit amplification of the AP.
For instance, AP activation is promoted on crushed Sephadex
whereas no amplification occurs on carboxymethyl Sephadex
which allows factor H to bind avidly to C3b [11, 12]. In
addition, it has been shown recently that specific antibodies can
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also influence the degree of AP activation induced by cellulosic
biomaterials in vitro [13, 14]. This might be important in
determining complement activation in vivo during dialysis.
Another type of interaction between biomaterials and blood
proteins is adsorption. The PAN membrane, which is made of a
copolymer of polyacrylonitrile and methallylsulfonate has im-
portant adsorptive properties [15]. For instance, 400 to 600 mg
of j32-microglobulin are removed weekly with a PAN dialyzer
by adsorption and mass transfer to the dialysis fluid [16, 17].
Since the accumulation of /32-microglobulin plays an important
role in the dialysis-related amyloidosis, this property of PAN
might be beneficial for patients undergoing chronic hemodialy-
sis [18]. The production of interleukin I (IL-i), a cytokine with
multiple physiologic and pathologic effects, is induced during
hemodialysis. IL-i has also been shown to be adsorbed to PAN
[19, 20]. A small amount of different complement proteins such
as Clq, C3 and C5 are adsorbed to PAN as well [21, 22].
However, most impressive has been the almost total adsorption
of C3a and possibly C5a, the powerful anaphylatoxins released
during complement activation by dialysis membranes [23]. This
observation might explain why hemodialysis with PAN in-
creases C3a and C5a only minimally and why there is almost no
transient drop in neutrophils at the start of dialysis.
A series of intriguing observations have been made by
Amadori et a! [21] some years ago. The incubation of serum
with PAN induced a decrease in total hemolytic complement
which did not correspond to complement activation, since no
C3 activation could be detected. It was hypothesized that PAN
removed and/or inactivated an essential complement compo-
nent. More recently in a preliminary study, Moore et al [24]
have examined the effect of dialysis circuits which incorporate
in series a cuprophan (Cu) and a PAN membrane. They showed
that PAN adsorbed C3a released by Cu, as expected. More
interesting was that PAN placed upstream of Cu reduced
complement activation by Cu, which again suggested that
plasma exposed to PAN lost a factor responsible for comple-
ment activation.
Factor D, a highly specific serine protease, cleaves factor B
bound to C3b, generating the C3bBb enzyme which is the AP
C3 convertase [25]. Factor D is the rate limiting enzyme of the
AP, and is present in a low concentration (2 g/ml) in plasma
[26, 27]. However, factor D levels are increased 10-fold in
patients with end-stage renal failure (ESRF) since factor D is
catabolized by the kidney under normal conditions [27—29]. The
function of factor D is not modified in renal failure. As shown in
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various in vitro assays, this high level of functionally active
factor D is responsible for enhanced activation of the AP [29,
30].
The present study was undertaken to determine whether
factor D might be lost or inactivated when plasma is exposed to
PAN.
Methods
Hemodialysis membranes
PAN (Hospal, AN69, Lyon, France), a copolymer of poly-
acrylonitrile and sodium methallyl sulfonate, and Cu (Gambro,
Lund, Sweden) fibers were prepared by cutting short fragments
of fibers (<4 mm) of new hollow fiber dialyzers.
PAN (surface: 1.2 m2) and cellulose acetate (CA, Baxter,
France, surface: 1.7 m2) hollow fiber dialyzers which had been
used to dialyze patients with end-stage renal failure (ESRF) (3.5
hr dialysis sessions, flow rate of 200 to 250 ml/min, dialysate
flow rate of 500 mI/mm) were immediately washed with one liter
of 15 m'vi NaCl. The dialysis compartment was filled with 15 mi
NaC1 and closed. The membrane-associated proteins were
eluted as described below.
Factor D
Human factor D was purified from the peritoneal fluid of
patients on chronic ambulatory peritoneal dialysis employing
three successive chromatographic steps: Bio-Rex 70 (Bio-Rad
Laboratories, Richmond, California, USA), Heparin-Sepharose
CL 6B and Mono-S FPLC (Pharmacia, Uppsala, Sweden) [31].
The protein was radiolabeled with '251-Bolton Hunter reagent
(Amersham, Buckinghamshire, UK) [32] to a specific activity of
0.95 Ci/zg of factor D. Free iodine was removed by gel
filtration on Sephadex G-25 (Pharmacia, Uppsala, Sweden).
Trichioroacetic acid precipitation (TCA, final concentration
10%) showed that 95% of the radioactivity was protein-bound.
The '251-factor D was dialyzed against PBS and aliquots were
kept frozen in liquid nitrogen until used. Sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE) [33] followed
by autoradiography and quantification of the blots by Phosphor-
imager (Image Quant Software FAST SCAN, Molecular Dy-
namics Ltd, Kemsing, UK) revealed one major band of 23 Kd,
which represented 95% of the radioactivity, and two minor
bands representing each 2.5%.
Factor D-depleted serum (RD) was prepared by immunoaf-
finity using rabbit IgG anti-factor D as previously described
[34].
In vitro assays with the dialysis membranes
Veronal buffered saline containing 0.5 mM MgC12 and 0.15
mM CaC12 (VBS) was used in all in vitro assays. Before
incubation with serum or with 1251-factor D, the dialyzer
membranes (PAN and Cu) were hydrated and equilibrated by
incubation with VBS + forone hour at 37°C, washed twice and
resuspended in VBS. Normal human serum (NHS) was
obtained by allowing freshly drawn venous blood from normal
donors to clot at room temperature for 30 minutes before
separation by centrifugation. The fresh serum was frozen in
liquid nitrogen and stored in aliquots at —80°C until used. This
procedure prevented significant complement activation in vitro.
Complement activation by PAN and Cu membranes. This
was assessed by measuring the C3 conversion to C3c (% of C3
activation induced by the membranes) using crossed immuno-
electrophoresis [35]. Mixtures containing 75 d of NHS and 225j.d of VBS were incubated with 15 mg of PAN or Cu
membranes for 30 minutes at 37°C. Controls included sponta-
neous C3 conversion of NHS diluted ito 4 in VBS, and C3
conversion induced by 10 mg of crushed Sephadex (Pharmacia;
provided by Prof. D. Labarre) which is known to be a potent
activator of the AP of complement [11, 12].
The concentrations of C3, C4 and factor B were measured by
single radial immunodiffusion using monospecific antisera
(Lucerna, Lucerne, CH).
Removal of hemolytic factor Dfrom serum. Various amounts
of membranes (5 to 45 mg) pre-equilibrated in VBS were
added to 75 .d of NHS and 225 /Ll of VBS + The mixtures were
incubated for 60 minutes at 37°C with gentle agitation. Residual
factor D hemolytic activity in the supernatants was measured
using a hemolytic plate assay and human RD serum [34] (limit of
sensitivity of the assay: 2.5% of the normal serum concentra-
tion of factor D). Note that 100% of hemolytic factor D
corresponds to 2 g/ml of factor D (normal serum concentra-
tion).
The functional activity of factor D bound to the PAN mem-
brane was assessed in a C3 converting assay. PAN fibers (40
mg) were first incubated with 50 pA of NHS diluted 1/4 in
VBS for 60 minutes at 37°C to adsorb factor D. Approxi-
mately 100 ng of factor D were adsorbed by this incubation, as
calculated from the disappearance of factor D from the NHS
and the known serum concentration of factor D (2 pg/mI). Then,
50 pA of RD serum were incubated with 150 pA of VBS and 5
pA of cobra venom factor (CVF; 0.3 mg/mI, 100 inhibitory U/mi;
Cordis, Miami, Florida, USA) at 37°C in the presence of either
0.5 ng of purified factor D (positive control), 40 mg of PAN
membrane only (negative control) or 40 mg of PAN membrane
which had bound approximately 100 ng of factor D by preincu-
bation with NHS. EDTA (10 mmol) was added after incubation
for 60 minutes and the percentage of C3 conversion determined.
Binding of'251-factor D. The binding of factor D to PAN and
Cu membranes was measured by adding 3 pA (12.5 ng) of
1251-factor D to various amounts of membranes (5 to 45 mg) in
a final volume of 300 pA of VBS (with 10 pA of NHS to avoid
nonspecific binding). The mixtures were incubated for 60 min-
utes at 37°C. The membranes were then washed three times in
VBS, and the percentage of 1251-factor D bound to the
membranes was counted.
Adsorption of factor D by PAN dialyzers
Fifty milliliters of NHS and 100 ml of whole heparinized
blood (1 U/ml) freshly drawn from a normal donor were run at
a flow rate of I ml/min through a hollow fiber PAN dialysis
ifiter, that had been rinsed with sterile isotonic saline via the
blood and dialysate compartments. The dialysate compartment
filled with NaCI 15 m was kept closed during the experiment.
Fractions of 4 ml were collected from the outlet and the residual
serum or plasma factor D in the fractions after the passage
through the filter were measured by the hemolytic plate assay.
In the experiment with heparinized blood, the total protein
content, C3 and C4 were also determined before and after the
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passage through the filter, respectively, by optical densitometry
and single radial immunodiffusion.
PAN and CA dialyzers were collected immediately at the end
of a regular dialysis session, and extensively washed with 15
mM NaCI. Proteins from the membranes were eluted with 2 M
NaC1, and the presence of hemolytic factor D in the eluates was
determined and quantitated. Total protein content in the eluates
was determined by optical densitometry.
The presence of antigenic factor D in the eluates of dialysis
membranes was also assessed by immunoblots after separation
of the proteins by SDS-PAGE. In brief, 40 ml of the eluates
were concentrated eightfold by using a YMS (43 mm) membrane
with a cut-off of 10 Kd (Amicon, Lausanne, Switzerland). The
concentrated eluate (40 d) and plasma (0.25 d) from a patient
with ESRF on hemodialysis were applied to 5 to 15% SDS-
PAGE under non-reducing conditions and transferred to nitro-
cellulose. The concentrated eluate from a CA filter was used as
control. The nitrocellulose was incubated overnight with 100 g
of anti-factor D mAb 72-96-25 [34]. Biotinylated sheep IgG
against mouse IgG (Amersham, H. Rahn and Co, Zurich,
Switzerland) was used as the second antibody. Finally, strepta-
vidin-horseradish peroxydase was added and revealed with
4-chloro-l-naphtol (BioRad, Zurich, Switzerland). On similar
nitrocellulose blots beta-2-microglobulin was detected using
specific rabbit polyclonal antibodies (Dakopatts, Denmark),
followed by 1251-protein G (Amersham) and revealed by auto-
radiography.
Plasma factor D levels in chronically hemodialyzed patients
before and after dialysis
EDTA-anticoagulated blood samples were collected before
(pre) and after (post) completion of dialysis in six patients with
ESRF dialyzed with PAN and in five patients dialyzed with CA
cellulose hollow fiber dialyzers. After centrifugation, plasma
samples were stored at —80°C until measurement of hemolytic
factor D. A normal plasma pool of 32 healthy blood donors was
used to define the normal concentration of hemolytic factor D.
1gM levels were measured by laser nephelometry, and used to
correct results for changes in hemoconcentration after dialysis.
Statistical analysis
The Student's t-test for paired samples was used to compare
the factor D levels before and after dialysis. The unpaired t-test
was used to compare pre-dialysis plasma factor D levels of
patients on PAN or CA, and to analyze data from in vitro
experiments. All values from in vitro experiments are reported
as the mean SEM.
Results
Complement activation by dialysis membranes in vitro
First, we studied the activation of C3 in NHS incubated with
PAN fibers, Cu fibers or crushed Sephadex. The formation of
C3c, the major breakdown product of C3, was maximal with
crushed Sephadex, intermediate with Cu, and minimal with
PAN (Fig. 1). In fact, the proportion of C3c formed in the
presence of PAN was not different from the control serum
incubated without any fibers. Different experiments were per-
formed to determine whether the absence of C3c formation in
serum incubated with PAN was due to adsorption of C3 and/or
Spontaneous PAN Cu Sephadex
activation
Fig. 1. Percentage of C3 conversion to C3c after incubation for 30
minutes at 37°C of NHS (spontaneous activation), or NHS in the
presence ofPANfibers (15 mg), Cu fibers (15 mg) or crushed sephadex(10 mg). Results are depicted as the mean SEM (N = 3). The % of C3
conversion was significantly higher in the Cu group as compared to the
PAN group (P < 0.01).
its major fragment C3c to the PAN fibers. Serum was first
exposed to crushed Sephadex which generated maximal forma-
tion of C3c. This serum was then incubated for 60 minutes at
37°C and overnight at 4°C with fresh PAN fibers. The total
concentration of C3 and the proportion of C3c present after
exposure to crushed Sephadex were not modified by the incu-
bation with PAN. These data indicate that, although some C3 or
C3b might bind to dialysis membranes, the proportion bound
was too low to be detected in our in vitro assays, and thus the
large differences observed between the three materials tested
were not due to loss of C3 or C3c by adsorption. Finally, the
absence of significant C3c formation induced by PAN in vitro
was in accordance with previous results [21] and with the
generally accepted reduced ability of PAN to activate comple-
ment as compared to cellulosic membranes [I].
Removal by PAN of a factor necessary for complement
activation by crushed Sephadex
To see whether PAN removed a factor necessary for com-
plement activation, normal serum was incubated with PAN
overnight at 4°C. This serum was then incubated for 30 minutes
at 37°C with crushed Sephadex. Under such conditions no
significant C3c formation was observed, which contrasted with
the result obtained using the NHS which had not been prein-
cubated with PAN (Table 1). The factor removed by PAN was
unlikely to be C3, since antigenic C3 concentration was not
modified, and similarly we could not demonstrate a significant
modification of factor B concentration after the pre-incubation
with PAN (the loss of factor B was only 10%). The third factor
tested was factor D. The addition of purified factor D restored
most of the capacity of serum to generate C3c in the presence of
crushed Sephadex.
Loss offunctional factor D from serum exposed to PAN
PAN was responsible for a dose dependent loss of hemolytic
factor D from normal serum (Fig. 2). No such loss was observed
with cuprophan. The disappearance of factor D suggested
adsorption to PAN. Thus, the PAN fibers were washed with
PBS and then exposed to 2 M NaCl. Hemolytic factor D was
0
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NHS incubated overnightb 73.0 3.4%
NHS incubated overnight with 10.4 0.9%
PAN (40 mg)
NHS incubated overnight with 58.9 4.7%
PAN (40 mg) + 150 ng
factor D
recovered in this eluate but not in the control experiment in
which PAN had been preincubated with serum immunochemi-
cally depleted of factor D (RD).
To see whether the factor D adsorbed to the PAN was
functional, RD was incubated with PAN fibers to which factor
D had been adsorbed by preincubation of PAN with NHS. This
RD + PAN/factor D did not behave differently from RD as the
addition of cobra venom factor (CVF), a potent activator of the
AP, did not generate significant amount of C3c (Table 2). In the
control experiment, RD was supplemented with purified factor
D to 0.5% of its normal concentration. This minimal amount of
factor D was sufficient to allow C3c formation by CVF. Thus,
factor D adsorbed to PAN had lost more than 99.5% of its
functional activity.
Binding of radiolabeled factor D to PAN
When 1251-factor D was incubated with various amounts of
PAN fibers in the presence of minimal amounts of normal
serum, there was a dose dependent binding of 1251-factor D to
the fibers (Fig. 3A). As shown by SDS-PAGE and autoradiog-
raphy analysis, all the '251-factor D bound to the PAN fibers
when 30 mg or more fibers were used (not shown). The binding
of radiolabeled factor D to the fibers was very rapid since 70%
Percentage of C3c formation
RD seruma 6.9 0.4%
RD serum + CVF 7.0 0.9%
RD serum + CVF + 0.5 ng factor D" 63.9 5.8%
RD serum + PAN/factor DC 8.2 1.0%
RD serum + CVF + PAN/factor D 7.5 0.5%
Results are reported as the mean SaM (N = 3).
a Assay: 50 d of RD diluted 1/4 in VBS, incubated for 60 mm at
37°C
b Factor D: 0.5 ng corresponds to 0.5% of the normal factor D
concentration
C PAN/factor D: 40 mg of PAN precoated with approximately 100 ng
of factor D
was bound in five minutes (Fig. 3B). No significant binding was
observed when Cu was used. Finally the binding of '251-factor D
was not modified by 10 mat EDTA or by 10 U/ml of heparin.
Adsorption of factor D by PAN dialysis filters
When 50 ml of NHS or 100 ml of whole heparinized blood (1
U/mi) were run for 60 minutes through a new PAN hollow fiber
dialyzer in vitro, the disappearance of factor D was almost
complete, since less than 3% of the hemolytic factor D could be
recovered after passage through the filter. Functional factor D
could be eluted with 2 M NaCI. No factor D was found in the
dialysate (60 ml) even after a 10-fold concentration using YMS
Amicon membranes. Since the factor D hemolytic assay could
detect concentrations as low as 50 ng/ml, we calculated that
under these conditions more than 99% of factor D disappear-
ance was due to adsorption. As expected, there was also a
non-specific adsorption of many proteins under these condi-
tions. Indeed, by measuring the plasma total protein content,
C3 and C4 before and after passage through the PAN filter
(experiment with heparinized blood), only 78% of total protein,
69% of C3 and 79% of C4 were recovered after passage through
the filter.
To see whether a similar phenomenon occurred in vivo during
dialysis with PAN, we studied two PAN dialyzers immediately
after the end of a dialysis session. After extensive washing with
15 ma'i NaC1, elution of membrane-associated proteins was
performed with 2 M NaC1. The proteins recovered were ana-
lyzed by SDS-PAGE and compared to the plasma of the two
patients with ESRF. The eluates contained many small molec-
ular weight proteins in addition to albumin (Fig. 4). One protein
was particularly abundant at a molecular wt of 24 Kd corre-
sponding to the expected molecular wt of factor D. By immu-
noblotting this protein was shown to be factor D (Fig. 5).
Another protein known to be adsorbed by PAN, that is,
/37-microglobulin, was shown to be present in the eluates as well
(Fig. 6). Quantitative analysis indicated that factor D was a
major component of the eluate since 38.4 mg of hemolytic factor
D were recovered from one PAN dialyzer, representing 34% of
the total proteins. Only 2 mg of /32-microglobulin were recov-
ered in this eluate, suggesting that the elution conditions did not
allow complete release of all the membrane-associated proteins
because higher amounts of f32-microglobulin have been reported
to be adsorbed by PAN dialyzers [16]. No factor D could be
recovered from two CA filters.
Table 1. Loss of alternative pathway function by pre-incubating
NHS with PAN membrane
Percentage of C3c formation
after incubation of NHS with
10 mg of crushed Sephadex°
Table 2. Factor D adsorbed to PAN is not functional
Results are reported as the mean SEM (N = 3).
a Assay: 75 d of NHS diluted 1/4 in VBS, for 30 mm at 37°C; C3c
in NHS before the assay <8%
"Overnight incubation at 4°C
100
75
0050()
0
E25
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Fig. 2. Percentage of hemolytic factor D remaining in solution after
incubation of NHS with various amounts of PAN (D) orCu (U)flbers.
Results are depicted as the mean SEM (N = 2).
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Fig. 4. SDS-PAGE analysis of proteins eluted from a PAN dialysis
filter, The filter was taken after a regular dialysis session of a patient
with ESRF, washed with 15 m NaCI and the proteins eluted with 2 M
NaCI. Lane A: plasma proteins of the patient; lane B: proteins eluted
from the PAN filter,
Modifications of factor D concentration during hemodialysis
with PAN
To see whether the in vitro findings of factor D adsorption to
PAN membranes might also be relevant for patients on chronic
hemodialysis, hemolytic plasma levels of factor D were mea-
sured before and at the end of dialysis sessions (Fig. 7). In six
Fig. 3. A. Percentage of binding of
radiolabelled factor D to various amounts of
PAN (El) and Cu (•)fibers, after 60 minutes
at 37°C. 8. Kinetics of binding of
radiolabelled factor D to 45 mg of PAN and
Cu fibers. The experiments were performed in
the presence of 10 d of NHS so as to avoid
non-specific binding. Results are depicted as
the mean SEM (N = 2).
patients dialyzed with PAN, there was a 81.4 9.1% decrease
in plasma factor D after dialysis (P < 0.001). To determine
whether factor D might also have been lost by mass transfer
into the dialysis fluid, we measured hemolytic factor D in six
samples of dialysis fluid taken during dialysis (at 30 mm
intervals) in two patients. Although these samples were first
concentrated 10-fold, none contained any hemolytic factor D.
Thus less than one milligram of hemolytic factor D was lost by
mass transfer given the sensitivity of the hemolytic assay, and
a dialysate flow rate of 500 mllmin for 3.5 hours (total: 105 liters
of dialysis fluid). By calculation it was estimated that dialysis on
PAN removed at least 48 mg of factor D per dialysis session.
Thus, PAN removed factor D mainly by adsorption. In five
patients dialyzed with CA, there was a 9.6 3.5% decrease in
factor D that could be explained by mass transfer of the protein
to the dialysis fluid, since significant amounts (approximately 10
mg of hemolytic factor D) were recovered in this compartment
in one patient. The mean predialytic level of factor D in plasma
was slightly but significantly lower in the patients dialyzed with
PAN as compared to CA (18.2 5.6 pg/ml versus 25.1 3.2
tgIml, P < 0.05).
Discussion
The main finding of this work was the very significant
adsorption of complement factor D by PAN dialysis membrane.
The second interesting finding was that factor D bound to PAN
was inactive, that is, incapable of enhancing complement acti-
vation on the dialysis membrane. The third and possibly most
relevant observation was that in patients with ESRF, the
plasma concentration of factor D dropped several-fold, reach-
ing almost normal values after dialysis with PAN.
The interactions between PAN and the complement cascade
are not simple. Based on the measurements of complement
fragments (C3a, C3d, C5a, C5b-9) and neutrophil counts, PAN
membrane has been classified as a weak activator of comple-
ment as compared to cellulosic membranes [1—8, 36, 371.
However, in view of its important adsorptive properties in
particular for the anaphylatoxins C3a and C5a, it has been
difficult to assess the real degree of complement activation
induced by PAN [15, 231. For this reason, we performed a
series of in vitro experiments to compare PAN with Cu fibers.
Fresh human serum was exposed to the two biomaterials, and
the activation of C3 was measured by its cleavage to C3c. Thus,
the results provided only indications on the relative capacity of
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PAN and Cu to activate complement. However, they were
unequivocal: PAN is a weaker activator of complement than
Cu, and this result was not due to adsorption of the complement
fragment measured (C3c).
The second point was to confirm the observations of Amadori
et a! and Moore et a! [21, 24]. Indeed, incubation of normal
serum with PAN removed a factor essential for complement
activation by the AP, and this factor was shown to be factor D.
The experiments reported here concurred to demonstrate an
efficient adsorption of factor D by PAN. In vitro, hemolytic
factor D was lost from whole serum exposed to PAN and was
recovered by elution with 2 M NaCl. This adsorption could be
studied directly by incubating purified radiolabeled factor D
with PAN fibers: there was a dose and time dependent binding
of radiolabeled factor D to PAN which was not observed with
cellulosic fibers. A similar efficient adsorption of factor D was
demonstrated using whole PAN dialyzers in vitro. Finally,
when PAN filters which had been used for dialysis were eluted
with 2 M NaCl, it was possible to recover intact antigenic and
functional factor Din the eluate. Almost 40 mg of factor D were
present in one PAN eluate, representing a third of all proteins
eluted. The striking enrichment in factor D might be an over-
estimate because factor D may be released more readily than
other proteins by 2 M NaCl. However, the 2 M NaC1 eluate of a
PAN filter is a convenient starting material for the purification
of human factor D. Indeed, purification of factor D has been
hampered by its low concentration in biological fluids [26, 31,
38].
Other proteins essential for AP function might have been
adsorbed by PAN as well. However, the demonstration that the
AP function of serum exposed to PAN was restored by purified
factor D suggested that adsorption of other proteins plays only
a minor role. Under conditions which depleted hemolytic factor
D by more than 95%, the losses of C3 and factor B were
minimal. From the eluates of PAN dialyzers, it was, however,
apparent that many other small molecular wt proteins bound
specifically to PAN. They included 2-microglobulin as ex-
pected [16, 17], and possibly C3a. It would be interesting to
define the remaining proteins as well to see which other
biologically active proteins are removed specifically by PAN.
The binding of factor D might enhance and focus complement
activation on the dialysis membrane. On the other hand, factor
20 k
A B C
Fig. 5. Detection of factor D in the proteins
eluted from the PAN filter by immunoblotting.
Lane A: purified factor D (500 ng); lane B:
plasma (0.25 rl) from the patient; lane C:
proteins eluted from the PAN filter. To note is
that factor D concentration was too low in
plasma to be detected by immunoblotting.
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Fig. 6. Detection of 132-microglobulin in the
proteins eluted from the PAN filter by
immunoblotting. Lane A: plasma from the
patient; lane B: proteins eluted from the PAN
filter. 132-microglobulin concentration was too
low in plasma to be detected by
immunoblotting.
j)
30
25
20
15
10
5
0
Pre Post
Fig. 7. Plasma levels of factor D before (pre) and after (post) dialysis
in six patients dialyzed with PAN filters (closed circles) and in five
patients dialysed with CA filters (open circles).
D bound to the membrane might be inactive because the binding
involves or modifies the site responsible for its enzymatic
activity. Using a very sensitive assay which detected 0.5% of
functional factor D, it was not possible to show any functional
factor D while bound to PAN. However, factor D hemolytic
activity was recovered after elution of factor D from PAN
fibers, suggesting that the binding to PAN involves the serine
protease enzymatic site, but does not modify it. Adsorption or
inhibition of factor D function on PAN might result in comple-
ment inhibition at the blood/membrane interface and contribute
to the reduced ability of such membranes to activate comple-
ment. Whether anionic sulfonate groups are critical for factor D
adsorption, as proposed for other substances such as anaphy-
latoxins [22], remains to be defined.
The drop in factor D concentration during hemodialysis with
PAN was substantial since more than 80% of circulating factor
D was removed at the end of dialysis. Considering the lower
detection limits of the hemolytic assay, it was estimated that
less than one milligram of factor D was present in the PAN
dialysate, that is, the removal of factor D by PAN occurred
mainly by protein adsorption. In patients dialyzed with CA, the
small reduction in hemolytic factor D after dialysis could be
explained by mass transfer of the protein to the dialysis fluid.
The large decrease in plasma factor D after dialysis with PAN
A B
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should decrease the hyperactivability of the AP of complement
observed in the plasma of patients with ESRF [30, 39, 40].
However, the effect on factor D levels was only transient since
just prior to the next dialysis session the levels were increased
again to very high values. The absence of a sustained effect
could be anticipated from the high rate of synthesis of factor D
and its almost exclusive renal catabolism [291. However, even a
transient decrease of factor D with PAN might be beneficial in
patients with end-stage renal disease undergoing hemodialysis,
since there are several reasons to suggest that the hyperactiva-
bility of the AP secondary to high factor D levels is detrimental
in ESRF [30, 40].
The adsorptive characteristics of dialysis membranes merit
further investigation to develop new biomaterials with even
better adsorptive properties for proteins of low molecular
weight, such as fl2-microglobulin and factor D, for which an
efficient removal might be beneficial in ESRF. Uremic toxins,
which include several small molecular wt proteins, might also
be removed more efficiently by biomaterials combining high
diffusing and adsorbing properties.
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Appendix. Abbreviations
End-stage renal failure
Polyacrylonitrile
Normal serum immunochemically depleted of
factor D
SDS-PAGE Sodium dodecylsulfate polyacrylamide gel
electrophoresisVBS + Veronal buffered saline
References
1. SCHULMAN 0, HAKIM RM: Recent advances in the biocompatibil-
ity of haemodialysis membranes. Nephrol Dial Transplant 6 (Suppl
2): 10—13, 1991
2. HAKIM RM, SCHAFER A!: Hemodialysis associated platelet activa-
tion and thrombocytopenia. Am J Med 78:575—580, 1985
3. HAKIM RM, BREILLAT J, LAZARUS JM, PORT FK: Complement
activation and hypersensitivity reactions to dialysis membranes. N
EngI J Med 311:878—882, 1984
4. HAKIM RM, FEAR0N DT, LAZARUS JM: Biocompatibility of dialy-
sis membranes: Effects of chronic complement activation. Kidney
mt 26:194—200, 1984
5. CHENOWETH DE, CHEUNG AK, HENDERSON LW: Anaphylatoxin
formation during hemodialysis: Effects of different dialyzer mem-
branes. Kidney mt 24:764—769, 1983
6. CRADDOCK PR, FEHR J, BRIGHAM KL, KRONENBERG RS, JACOB
HS: Complement and leucocyte-mediated pulmonary dysfunction
in hemodialysis. N Engi J Med 296:769—774, 1977
7. IvANovIcH P. CHENOWETH DE, SCHMIDT R, KLINKMANN H,
BOXER LA, JACOB HS, HAMMERSCHMIDT DE: Symptoms and
activation of granulocytes and complement with two dialysis mem-
branes. Kidney mt 24:758—763, 1983
8. JANATOVA J, CHEUNG AK, PARKER CJ: Biomedical polymers differ
in their capacity to activate complement. Complement Inflamm
8:61—69, 1991
9. CHEUNG AK, PARKER CJ, WILCOx L, JANATOvA J: Activation of
the alternative pathway of complement by cellulosic hemodialysis
membranes. Kidney mt 36:257—265, 1989
10. KAZATCHKINE MD, CARRENO MP: Activation of the complement
system at the interface between blood and artificial surfaces.
Biomaterials 9:30—35, 1988
11. CARRENO MP, LABARRE D, MAILLET F, JOZEFOWICZ M, KAZA-
TCHKINE MD: Regulation of the human alternative complement
pathway: Formation of a ternary complex between factor H,
surface bound C3b and chemical groups on non-activating surfaces.
Eurllmmunol 19:2145—2150, 1989
12. CARRENO MP, LABARRE D, JOZEFOWICZ M, KAZATCHKINE MD:
The ability of sephadex to activate human complement is sup-
pressed in specifically substituted functional sephadex derivatives.
Mol Immunol 25:165—171, 1988
13. CARRENO MP, MAILLET F, LABARRE D, JOZEFOWICZ M, KAZA-
TCHKINE MD: Specific antibodies enhance Sephadex-induced acti-
vation of the alternative complement pathway in human serum.
Biomaterials 9:514—518, 1988
14. MAILLET F, KAZATCHKINE MD: Specific antibodies enhance alter-
native complement pathway activation by cuprophan. Nephrol Dial
Transplant 6: 193—197, 1991
15, CHEUNG AK, CHENOWETH DE, OTSUKA D, HENDERSON LW:
Compartmental distribution of complement activation products in
artificial kidneys. Kidney mt 30:74—80, 1986
16. GOLDMAN M, DHAENE M, VANHERWEGHEM J-L: Removal of
/32-microglobulin by adsorption on dialysis membranes. Nephrol
Dial Transplant 2:576—577, 1987
17. ZINGRAFF J, BEYNE P, URENA M, UZAN M, NGUYEN KHOA M,
DESCAMPS-LATSCHA B, DRUEKE T: Influence of hemodialysis
membranes on /32-microglobulin kinetics: In vivo and in vitro
studies, Nephrol Dial Transplant 3:284—290, 1988
18. KOCH KM: Dialysis-related amyloidosis. Kidney mt 41:1416—1429,
1992
19. LAUDE-SHARP M, CAROFF M, SIMARD L, PUSINERI C, KAZATCH-
KINE M, HAEFFNER-CAvAILLON N: Induction of IL-i during he-
modialysis: Transmembrane passage of intact endotoxins (LPS).
Kidney mt 38:1089-1094, 1990
20. LONEMANN G, K0CI-! KM, SHALDON S, DINARELLO CA: Studies
on the ability of hemodialysis membranes to induce, bind, and clear
human interleukin-1. J Lab Clin Med 112:76—86, 1988
21. AMADORI A, CANDI P, SASDELLI M, MAS5AI G, FAvILLA 5,
PASSALEVA A, RICCI M: Hemodialysis leukopenia and complement
function with different dialyzers. Kidney mt 24:775—781, 1983
22. CHEUNG AK: Adsorption of unactivated complement proteins by
hemodialysis membranes. Am J Kidney Dis 14:472—477, 1989
23. CHEUNG AK, PARKER CJ, WILCOX LA, JANATOVA J: Activation of
complement by hemodialysis membranes: Polyacrylonitrile binds
more C3a than cuprophan. Kidney list 37:1055—1059, 1990
24. MOORE B, WALSH J, SCHULMAN 6, ARBEIT L: Polyacrylonitrile
dialysis membranes scavenge C3a desArg in man. (abstract) Kidney
list 35:256, 1989
25. VOLANAKIS JE: Participation of C3 and its ligands in complement
activation, in Current Topics in Microbiology and Immunology
(153: The Third Component of Complement), edited by LAMBRIS
JD, Berlin, Springer Verlag, 1989, p. 1
26. LESAVRE PH, MULLER-EBERHARD HJ: Mechanism of action of
factor D of the alternative complement pathway. J Exp Med
148:1498—1509, 1978
27. VOLANAKIS JE, BARNUM SR, GIDDENS M, GALLA JH: Renal
filtration and catabolism of complement protein D. N Engi J Med
312:395—399, 1985
AP
CA
CVF
Cu
ESRF
PAN
RD
Alternative pathway
Cellulose acetate
Cobra venom factor
Cuprophan
Pascual and SchfferIi: Adsorption of factor D by polyacrylonitrile 911
28, STURFELT G, KELLER C, TRUEDSONN L, THYSELL H: Complement
factor D in serum. Scand J Rheum 14:315—317, 1985
29. PASCUAL M, STEIGER G, ESTREICHER J, MACON K, VOLANAKIS
JE, SCHIFFERLI JA: Metabolism of complement factor D in renal
failure. Kidney mt 34:529—536, 1988
30. PASCUAL M, PACCAUD JP, MACON K, VOLANAKIS JE, SCHIFFERLI
JA: Complement activation by the alternative pathway is modified
in renal failure: The role of factor D. Clin Nephrol 32:185—193, 1989
31. CATANA E, SCHIFFERLI JA: Purification of human complement
factor D from the peritoneal fluid of patients on chronic ambulatory
peritoneal dialysis. J Im,nunoi Meth 138:265—271, 1991
32. BOLTON AE, HUNTER WM: The labelling of proteins to high
specific radioactivities by conjugation to a '251-containing acylating
agent. Biochem J 133:529—539, 1973
33. LAEMMLI UK: Cleavage of structural proteins during the assembly
of the head of bacteriophage T4. Nature 227:680-685, 1970
34. PASCUAL M, CATANA E, SPERTINI F, MACON K, VOLANAKIS JE,
SCHIFFERLI JA: A monoclonal antibody which blocks the function
of factor D of human complement. J Immunol Meth 127:263—269,
1990
35. LAURELL CB: Quantitative estimation of proteins by electrophore-
sis in agarose gels containing antibodies. Anal Biochem 15:45—52,
1966
36. WEGMULLER E, MONTANDON A, NYDEGGER U, DESCOEUDRES C:
Biocompatibility of different hemodialysis membranes: Activation
of complement and leucopenia. mt J Artif Organ 9:85—92, 1986
37. PERTOsA G, TARANTINO EA, MARFELLA C, GESUALDO L, SCHENA
FP: Effect of different hemodialysis procedures on C5b-9 genera-
tion. (abstract) Complement Inflamm 8:209, 1991
38. VOLANAKIS JE, MACON KM: Isolation of complement protein D
from urine of patients with Fanconi's syndrome. Anal Biochem
163:242—246, 1987
39. OPPERMANN M, HAUBITZ M, QUENTIN E, GOTZE 0: Complement
activation in patients with renal failure as detected through the
quantitation of fragments of the complement proteins C3, CS, and
factor B. Kiln Wochenschr 66:857—864, 1988
40. OPPERMANN M, KURTS C, Zinaz R, QUENTIN E, WEBER MH,
GOTZE 0: Elevated plasma levels of the immunosuppressive com-
plement fragment Ba in renal failure. Kidney mt 40:939—947, 1991
